Synonyms: Arelili® | Ariely® | HTI-1088 | HTI1088 | SHR-1316 | SHR1316
adebrelimab is an approved drug (China NMPA (2023))
Compound class:
Synthetic organic
Comment: Adebrelimab (SHR-1316; HTI-1088) is a chimeric humanized IgG4κ anti-PD-L1 monoclonal antibody.
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (China NMPA (2023)) |
International Nonproprietary Names | |
INN number | INN |
11300 | adebrelimab |
Synonyms |
Arelili® | Ariely® | HTI-1088 | HTI1088 | SHR-1316 | SHR1316 |
Database Links | |
Specialist databases | |
IMGT/mAb-DB | 999 |
Other databases | |
GtoPdb PubChem SID | 491299867 |
Search PubMed clinical trials | adebrelimab |
Search PubMed titles | adebrelimab |
Search PubMed titles/abstracts | adebrelimab |